Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SAP vs MRNA✓SelectedUSD · MRNASAP vs MRNA performance historyLatest closeAs of-4.84%11/17
Stock and ETF performance explorer

SAP vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+151.2%
MRNA return
+840.0%
Excess return
-688.8%
Maximum drawdown
-52.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-4.8%-3.9%-0.9%-4.7%
7D-4.8%-17.6%+12.7%-4.2%
30D-0.8%-5.1%+4.3%-0.8%
3M+7.1%+220.8%-213.8%-0.9%
6M+31.3%+321.7%-290.4%+19.2%
YTD-6.8%+601.3%-608.1%-18.6%
1Y-5.2%+735.2%-740.5%-18.3%
3Y+54.2%+170.5%-116.3%+39.2%
5Y+70.5%-14.6%+85.1%+59.7%
All+151.2%+840.0%-688.8%+115.2%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling